advertisement

---

Yu X 13

Showing records 1 to 13 | Display all abstracts from Yu X

128774 Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
Lin Z
Frontiers in pharmacology 2025; 16: 1623921

---

128768 Postoperative amblyopia in children with congenital cataracts: a systematic review and meta-analysis
Hailaiti A
Italian journal of pediatrics 2025; 51: 141

---

127599 Genetic Spectrum and Genotype-Phenotype Correlations in a Chinese Cohort With Nanophthalmos With Secondary Angle-Closure Glaucoma
Yu X
Investigative Ophthalmology and Visual Science 2025; 66: 9

---

128774 Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
Xue J
Frontiers in pharmacology 2025; 16: 1623921

---

128768 Postoperative amblyopia in children with congenital cataracts: a systematic review and meta-analysis
Yu X
Italian journal of pediatrics 2025; 51: 141

---

127599 Genetic Spectrum and Genotype-Phenotype Correlations in a Chinese Cohort With Nanophthalmos With Secondary Angle-Closure Glaucoma
Zhao H
Investigative Ophthalmology and Visual Science 2025; 66: 9

---

128768 Postoperative amblyopia in children with congenital cataracts: a systematic review and meta-analysis
Yao K
Italian journal of pediatrics 2025; 51: 141

---

127599 Genetic Spectrum and Genotype-Phenotype Correlations in a Chinese Cohort With Nanophthalmos With Secondary Angle-Closure Glaucoma
Gao Y
Investigative Ophthalmology and Visual Science 2025; 66: 9

---

128774 Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
Yang M; Yu X
Frontiers in pharmacology 2025; 16: 1623921

---

128768 Postoperative amblyopia in children with congenital cataracts: a systematic review and meta-analysis
Shentu X
Italian journal of pediatrics 2025; 51: 141

---

127599 Genetic Spectrum and Genotype-Phenotype Correlations in a Chinese Cohort With Nanophthalmos With Secondary Angle-Closure Glaucoma
Zhou T
Investigative Ophthalmology and Visual Science 2025; 66: 9

---

128774 Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
Zhong J
Frontiers in pharmacology 2025; 16: 1623921

---

127599 Genetic Spectrum and Genotype-Phenotype Correlations in a Chinese Cohort With Nanophthalmos With Secondary Angle-Closure Glaucoma
Deng L; Zhang M; Zhong H; Mei F; Li Z; Sun L; Zhang T; Shi Y; Fan Z
Investigative Ophthalmology and Visual Science 2025; 66: 9

---